Research ArticleOriginal Article
Open Access
Effect of a low dose of empagliflozin on short-term outcomes in type 2 diabetics with acute coronary syndrome after percutaneous coronary intervention
Seyed Mohammad H. Adel, Fateme Jorfi, Hoda Mombeini, Homeira Rashidi and Saad Fazeli
Saudi Medical Journal May 2022, 43 (5) 458-464; DOI: https://doi.org/10.15537/smj.2022.43.5.20220018
Seyed Mohammad H. Adel
From the Department of Cardiology (Adel, Jorfi, Mombeini, Fazeli), from the Atherosclerosis Research Center (Adel, Jorfi, Mombeini), and from the Department of Internal Medicine (Rashidi), Ahvaz Jundishapur University of Medical Sciences, Imam Khomeini Hospital, Ahvaz, Iran.
MDFateme Jorfi
From the Department of Cardiology (Adel, Jorfi, Mombeini, Fazeli), from the Atherosclerosis Research Center (Adel, Jorfi, Mombeini), and from the Department of Internal Medicine (Rashidi), Ahvaz Jundishapur University of Medical Sciences, Imam Khomeini Hospital, Ahvaz, Iran.
MDHoda Mombeini
From the Department of Cardiology (Adel, Jorfi, Mombeini, Fazeli), from the Atherosclerosis Research Center (Adel, Jorfi, Mombeini), and from the Department of Internal Medicine (Rashidi), Ahvaz Jundishapur University of Medical Sciences, Imam Khomeini Hospital, Ahvaz, Iran.
MDHomeira Rashidi
From the Department of Cardiology (Adel, Jorfi, Mombeini, Fazeli), from the Atherosclerosis Research Center (Adel, Jorfi, Mombeini), and from the Department of Internal Medicine (Rashidi), Ahvaz Jundishapur University of Medical Sciences, Imam Khomeini Hospital, Ahvaz, Iran.
MDSaad Fazeli
From the Department of Cardiology (Adel, Jorfi, Mombeini, Fazeli), from the Atherosclerosis Research Center (Adel, Jorfi, Mombeini), and from the Department of Internal Medicine (Rashidi), Ahvaz Jundishapur University of Medical Sciences, Imam Khomeini Hospital, Ahvaz, Iran.
MD
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Effect of a low dose of empagliflozin on short-term outcomes in type 2 diabetics with acute coronary syndrome after percutaneous coronary intervention
Seyed Mohammad H. Adel, Fateme Jorfi, Hoda Mombeini, Homeira Rashidi, Saad Fazeli
Saudi Medical Journal May 2022, 43 (5) 458-464; DOI: 10.15537/smj.2022.43.5.20220018
Effect of a low dose of empagliflozin on short-term outcomes in type 2 diabetics with acute coronary syndrome after percutaneous coronary intervention
Seyed Mohammad H. Adel, Fateme Jorfi, Hoda Mombeini, Homeira Rashidi, Saad Fazeli
Saudi Medical Journal May 2022, 43 (5) 458-464; DOI: 10.15537/smj.2022.43.5.20220018
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.